Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: prespecified subgroup analyses from JAVELIN Bladder 100

被引:0
|
作者
Lumba, Sumit [1 ]
Grivas, Petros [2 ]
Park, Se Hoon [3 ]
Voog, Eric [4 ]
Caserta, Claudia [5 ]
Valderrama, Begona P. [6 ]
Gurney, Howard [7 ]
Kalofonos, Haralabos [8 ]
Radulovic, Sinisa [9 ]
Demey, Wim [10 ]
Ullen, Andres [11 ]
Loriot, Yohann [12 ]
Sridhar, Srikala S. [13 ]
Tsuchiya, Norihiko [14 ]
Kopyltsov, Evgeny [15 ]
Gupta, Shilpa [16 ]
Huang, Bo [17 ]
Costa, Nuno [18 ]
Blake-Haskins, John A. [19 ]
di Pietro, Alessandra [20 ]
Powles, Thomas [21 ]
机构
[1] Tweed Hosp Canc Ctr, Tweed Heads, NSW, Australia
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[3] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
[4] Ctr Jean Bernard Clin Victor Hugo, Le Mans, France
[5] Azienda Osped S Maria, Med Oncol Unit, Terni, Italy
[6] Hosp Univ Virgen Rocio, Seville, Spain
[7] Macquarie Univ, Sydney, NSW, Australia
[8] Univ Gen Hosp Patras, Med Oncol, Patras, Greece
[9] Inst Oncol & Radiol Serbia, Belgrade, Serbia
[10] AZ KLINA, Brasschaat, Belgium
[11] Karolinska Univ Hosp, Genitourinary Oncol Unit, Solna, Sweden
[12] Univ Paris Saclay, Gustave Roussy, INSERM, U981, Villejuif, France
[13] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[14] Yamagata Univ, Fac Med, Yamagata, Japan
[15] State Inst Healthcare Reg Clin Oncol Dispensary, Omsk, Russia
[16] Cleveland Clin, Cleveland, OH 44106 USA
[17] Pfizer, Groton, CT USA
[18] Pfizer, Porto Salvo, Portugal
[19] Pfizer, La Jolla, CA USA
[20] Pfizer Srl, Milan, Italy
[21] Queen Mary Univ London, St Bartholomews Hosp, Expt Canc Med Ctr, Barts Canc Inst, London, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
abs8
引用
收藏
页码:42 / 43
页数:2
相关论文
共 50 条
  • [1] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: Prespecified subgroup analyses from JAVELIN Bladder 100
    Lumba, Sumit
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Kalofonos, Haralabos
    Radulovic, Sinisa
    Demey, Wim
    Ullen, Anders
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Kopyltsov, Evgeny
    Gupta, Shilpa
    Huang, Bo
    Costa, Nuno
    Blake-Haskins, John A.
    di Pietro, Alessandra
    Powles, Thomas
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 126 - 126
  • [2] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy
    Gurney, Howard
    Loriot, Yohann
    Powles, Thomas
    Duran, Climent Miguel
    Sridhar, Srikala
    Bellmunt, Joaquim
    Petrylak, Daniel
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    Di Pietro, Alessandra
    Grivas, Petros
    Sternberg, Cora
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 46 - 46
  • [3] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy
    Powles, Thomas
    Loriot, Yohann
    Duran, Miguel A. Climent
    Sridhar, Srikala
    Bellmunt, Joaquim
    Petrylak, Daniel P.
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    di Pietro, Alessandra
    Grivas, Petros
    Sternberg, Cora N.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 132 - 133
  • [4] Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis
    Yoshihiko Tomita
    Yoshiaki Yamamoto
    Norihiko Tsuchiya
    Hiroomi Kanayama
    Masatoshi Eto
    Hideaki Miyake
    Thomas Powles
    Mizuki Yoshida
    Yuichiro Koide
    Yoshiko Umeyama
    Alessandra di Pietro
    Hirotsugu Uemura
    [J]. International Journal of Clinical Oncology, 2022, 27 : 383 - 395
  • [5] Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis
    Tomita, Yoshihiko
    Yamamoto, Yoshiaki
    Tsuchiya, Norihiko
    Kanayama, Hiroomi
    Eto, Masatoshi
    Miyake, Hideaki
    Powles, Thomas
    Yoshida, Mizuki
    Koide, Yuichiro
    Umeyama, Yoshiko
    di Pietro, Alessandra
    Uemura, Hirotsugu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (02) : 383 - 395
  • [6] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: analysis of time to end of next-line therapy in JAVELIN Bladder 100
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Kopyltsov, Evgeny
    Gurney, Howard
    Muniz, Queiroz Borges David
    Rolland, Frederic
    Als, Anne Birgitte
    Valderrama, Begona
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    di Pietro, Alessandra
    Powles, Thomas
    Bellmunt, Joaquim
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 45 - 45
  • [7] AVELUMAB FIRST-LINE MAINTENANCE PLUS BEST SUPPORTIVE CARE VS BEST SUPPORTIVE CARE ALONE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF TIME TO END OF NEXT-LINE THERAPY IN JAVELIN BLADDER 100
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Kopyltsov, Evgeny
    Gurney, Howard
    Borges Muniz, David Queiroz
    Rolland, Frederic
    Als, Anne Birgitte
    Valderrama, Begona P.
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert J.
    di Pietro, Alessandra
    Powles, Thomas
    Bellmunt, Joaquim
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E765 - E765
  • [8] Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma
    Grivas, Petros
    Kopyltsov, Evgeny
    Su, Po-Jung
    Parnis, Francis X.
    Park, Se Hoon
    Yamamoto, Yoshiaki
    Fong, Peter C.
    Tournigand, Christophe
    Duran, Miguel A. Climent
    Bamias, Aristotelis
    Caserta, Claudia
    Chang, Jane
    Cislo, Paul
    di Pietro, Alessandra
    Wang, Jing
    Powles, Thomas
    [J]. EUROPEAN UROLOGY, 2023, 83 (04) : 320 - 328
  • [9] Avelumab first-line maintenance plus best supportive care (BSC) vs. BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Asian subgroup analysis
    Lee, Jae-Lyun
    Desai, Chirag
    Park, Se Hoon
    Tsuchiya, Norihiko
    Su, Po-Jung
    Chan, Timothy Tim Wai
    Gurney, Howard
    Gao, Seasea
    Wang, Jing
    Sandner, Robin
    di Pietro, Alessandra
    Eto, Masatoshi
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 256.e17 - 256.e25
  • [10] Avelumab first-line (1L) maintenance plus best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100
    Grivas, P.
    Park, S. H.
    Voog, E.
    Caserta, C.
    Perez Valderrama, B.
    Gurney, H.
    Kalofonos, H.
    Radulovic, S.
    Demey, W.
    Ullen, A.
    Loriot, Y.
    Sridhar, S. S.
    Tsuchiya, N.
    Kopyltsov, E.
    Gupta, S.
    Huang, B.
    Costa, N.
    Blake-Haskins, J. A.
    di Pietro, A.
    Powles, T. B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S555 - S556